» Authors » Eva Bock

Eva Bock

Explore the profile of Eva Bock including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 296
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kraus A, Rabe E, Kowall B, Schuldt K, Bock E, Stang A, et al.
Vasa . 2024 Mar; 53(2):145-154. PMID: 38426384
The aim of this publication is to demonstrate similarities and differences in the association of risk factors with the prevalence of different manifestations of chronic venous disease (CVD), like varicose...
2.
Feldhaus T, Falke S, von Gruchalla L, Maisch B, Uhlmann C, Bock E, et al.
Psychiatry Res . 2018 Jan; 261:391-399. PMID: 29353769
Negative attitudes towards medication in schizophrenia patients are one major factor contributing to non-adherence behavior. Besides, self-stigmatization represents another frequent and important obstacle in patients suffering from psychotic disorders. Here,...
3.
Surmann M, von Gruchalla L, Falke S, Maisch B, Uhlmann C, Bock E, et al.
Psychiatry Res . 2017 Jun; 255:314-320. PMID: 28601714
Different aspects of self-stigmatization represent barriers for recovery in patients with psychosis disorders. It is unclear whether addressing patient's competence and control beliefs could attenuate the extent of self-stigmatization. The...
4.
Burmeister J, Holle D, Bock E, Ose C, Diener H, Obermann M
Trials . 2015 Dec; 16:550. PMID: 26634453
Background: Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side...
5.
Obermann M, Bock E, Sabev N, Lehmann N, Weber R, Gerwig M, et al.
J Neurol . 2015 Jun; 262(9):2083-91. PMID: 26092518
To investigate the long-term outcome of interdisciplinary treatment in a tertiary care neuro-otology institution after 2 years as part of the Dizziness and Vertigo Registry study. Risk factors associated with...
6.
Schramm S, Moebus S, Lehmann N, Galli U, Obermann M, Bock E, et al.
Cephalalgia . 2014 Dec; 35(10):853-63. PMID: 25480807
Introduction: We studied the association between stress intensity and headache frequency for tension-type headache (TTH), migraine and migraine with coexisting TTH (MigTTH). Method: We studied a population-based sample of 5159...
7.
Rabe E, Hertel S, Bock E, Hoffmann B, Jockel K, Pannier F
J Dtsch Dermatol Ges . 2013 Feb; 11(3):257-61. PMID: 23425401
Background: Despite the frequent use of medical compression stockings (MCS), reliable data are lacking on the frequency of MCS use and experience of patients with the treatment. Patients And Methods:...
8.
Ranzinger J, Krippner-Heidenreich A, Haraszti T, Bock E, Tepperink J, Spatz J, et al.
Nano Lett . 2009 Sep; 9(12):4240-5. PMID: 19772290
Cellular apoptosis, the prototype of programmed cell death, can be induced by activation of so-called death receptors. Interestingly, soluble and membrane-bound members of death receptor ligands can differentially activate their...
9.
Huang J, Grater S, Corbellini F, Rinck S, Bock E, Kemkemer R, et al.
Nano Lett . 2009 Feb; 9(3):1111-6. PMID: 19206508
We herein present a novel platform of well-controlled ordered and disordered nanopatterns positioned with a cyclic peptide of arginine-glycine-aspartic acid (RGD) on a bioinert poly(ethylene glycol) background, to study whether...
10.
Steinmetz N, Bock E, Richter R, Spatz J, Lomonossoff G, Evans D
Biomacromolecules . 2008 Jan; 9(2):456-62. PMID: 18197628
The development of multilayered thin film assemblies containing (bio)molecules is driven by the need to miniaturize sensors, reactors, and biochips. Viral nanoparticles (VNPs) have become popular nanobuilding blocks for material...